More than a bridging therapy: Targeting CD123 with rapidly switchable universal CAR-T cells for treatment of acute leukemia

被引：0

作者：

Loff, Simon ^{[1
]}

Meyer, Jan-Erik ^{[2
]}

Spehr, Johannes ^{[2
]}

Riewaldt, Julia ^{[2
]}

Gruender, Cordula ^{[1
]}

Schreiber, Maria ^{[1
]}

Bachmann, Michael ^{[3
]}

Pehl, Michael ^{[1
]}

Ehninger, Gerhard ^{[4
]}

Ehninger, Armin ^{[1
]}

Cartellieri, Marc ^{[2
]}

机构：

[1] Gemoab Monoclonals GmbH, Dresden, Germany

[2] Cellex Patient Treatment GmbH, Dresden, Germany

[3] Helmholtz Zentrum Dresden Rossendorf eV, Dresden, Germany

[4] Cellex Gesell Zellgewinnung mbH, Dresden, Germany

来源：

CANCER RESEARCH | 2020年 / 80卷 / 16期

关键词：

D O I：

10.1158/1538-7445.AM2020-4232

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4232

引用

页数：2

共 50 条

[41] Adoptive immunotherapy of acute myeloid leukemia (AML) with allogenic CAR t-cells targeting CD123.
Galetto, Roman
Lebuhotel, Celine
Francon, Patricia
Gouble, Agnes
Smith, Julianne
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[42] Peptide-scFv Bispecific CAR-T Cells Targeting Acute Myeloid Leukemia
Zoine, Jaquelyn T.
Hebbar, Nikhil
Moore, Sarah E.
Langfitt, Deanna M.
Ibanez, Jorge A.
Talbot, Lindsay
Krenciute, Giedre
Gottschalk, Stephen
Velasquez, M. Paulina
MOLECULAR THERAPY, 2022, 30 (04) : 48 - 48
[43] Allogeneic TCRai3-deficient CAR T -cells targeting CD123 effectively eliminate myeloid leukemia cells in vitro and in vivo PDX mice
Guzman, Monica L.
Zong, Hongliang
Sugita, Mayumi
Lara-Martinez, Luis A.
Bystrom, Laura M.
Cruz, Nicole M.
Galetto, Roman
Gouble, Agnes
Lebuhotel, Celine
Bank, Alexander
Smith, Julianne
Roboz, Gail J.
CANCER RESEARCH, 2016, 76
[44] SS30, a novel thioaptamer targeting CD123, inhibits the growth of acute myeloid leukemia cells
Wang, Meng
Wu, Haibin
Duan, Mingyue
Yang, Ying
Wang, Guoxia
Che, Fengyu
Liu, Bailing
He, Wei
Li, Qiao
Zhang, Liyu
LIFE SCIENCES, 2019, 232
[45] Expansion kinetics and cytokine profiles of UniCAR-T-CD123, a rapidly switchable two-component CAR-T therapy, in patients with relapsed/refractory AML.
Ehninger, Armin
Riewaldt, Julia
Gruender, Cordula
Franke, Kristin
Schreiber, Maria
Wermke, Martin
Kraus, Sabrina
Kreissig, Carla
Koedam, Jan
Pehl, Michael
Ehninger, Gerhard
Cartellieri, Marc
CANCER RESEARCH, 2021, 81 (13)
[46] Emerging learnings in cell therapy: novel binding domains, universal CAR-T cells, and more
Rotte, Anand
FRONTIERS IN ONCOLOGY, 2024, 14
[47] Tandem bispecific CD123/CLL-1 CAR-T cells exhibit specific cytolytic effector functions against human acute myeloid leukaemia
Wang, Xiang-Yu
Bian, Mei-Ru
Lin, Guo-Qiang
Yu, Lei
Zhang, Yan-Ming
Wu, De-Pei
EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (01) : 83 - 93
[48] CAR-T cells dual-target CD123 and NKG2DLs to eradicate AML cells and selectively target immunosuppressive cells
Jin, Xin
Xie, Danni
Sun, Rui
Lu, Wenyi
Xiao, Xia
Yu, Yibing
Meng, Juanxia
Zhao, Mingfeng
ONCOIMMUNOLOGY, 2023, 12 (01):
[49] CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia
Jinghua Wang
Siyu Chen
Wei Xiao
Wende Li
Liang Wang
Shuo Yang
Weida Wang
Liping Xu
Shuangye Liao
Wenjian Liu
Yang Wang
Nawei Liu
Jianeng Zhang
Xiaojun Xia
Tiebang Kang
Gong Chen
Xiuyu Cai
Han Yang
Xing Zhang
Yue Lu
Penghui Zhou
Journal of Hematology & Oncology, 11
[50] CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia
Wang, Jinghua
Chen, Siyu
Xiao, Wei
Li, Wende
Wang, Liang
Yang, Shuo
Wang, Weida
Xu, Liping
Liao, Shuangye
Liu, Wenjian
Wang, Yang
Liu, Nawei
Zhang, Jianeng
Xia, Xiaojun
Kang, Tiebang
Chen, Gong
Cai, Xiuyu
Yang, Han
Zhang, Xing
Lu, Yue
Zhou, Penghui
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11

← 1 2 3 4 5 →